Decision to list medical devices supplied by Device Technologies New Zealand Pty Limited
We are pleased to announce the approval of listing agreements for the supply of medical devices to Health New Zealand | Te Whatu Ora hospitals.
What we’re doing
We are pleased to announce the approval of listing agreements with Device Technologies New Zealand Pty Limited (“Device Technologies”) in the following category from 1 April 2024:
In summary this will result in:
- Adhesive, sealant, and haemostat products from Device Technologies being listed in Part III of Section H of the Pharmaceutical Schedule from 1 April 2024 under a national agreement that all Health New Zealand | Te Whatu Ora hospitals may purchase under (“Agreement”); and
- Health New Zealand | Te Whatu hospitals being able to continue to purchase other suppliers’ brands of the medical devices as the Agreement is not for sole supply.
Any changes to the original proposal?
This decision was subject to a consultation letter dated 14 February 2024.
No changes have been made to the original proposal as a result of the consultation.
Who we think will be most interested
- Health New Zealand | Te Whatu Ora Hospital staff, including but not limited to:
- Emergency service personnel
- General ward clinicians and nurses
- Operating theatre nurses
- Surgeons
- Procurement and supply chain personnel
- Suppliers and wholesalers
Details about this decision
The RFP was for non-exclusive national agreements for listing on the Pharmaceutical Schedule.
After completing the RFP evaluation process, and consulting on the provisional agreement reached with Device Technologies, Pharmac has decided to list the range of adhesives, sealants, and haemostats supplied by Device Technologies in Part III of Section H of the Pharmaceutical Schedule from 1 April 2024.
Health New Zealand | Te Whatu Ora hospitals can continue to choose which adhesive, sealant, and haemostat products they purchase, including those from other suppliers. Health New Zealand | Te Whatu Ora hospitals that purchase products in this category must do so under the terms and conditions, including pricing, in the Agreement from 1 April 2024.
Our response to what you told us
We’re really grateful for the time people took to review this proposal. We received supportive responses from our direct engagement with select Health New Zealand | Te Whatu Ora procurement personnel and no material feedback from other respondents.
If you have any questions about this decision, you can email us at enquiry@pharmac.govt.nz; or call our toll free number (9 am to 5 pm, Monday to Friday) on 0800 66 00 50.